56 studies found for:    "Adrenocortical carcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Adrenocortical carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Recurrent Adrenocortical Carcinoma;   Stage III Adrenocortical Carcinoma;   Stage IV Adrenocortical Carcinoma
Intervention: Drug: R-(-)-gossypol acetic acid
2 Completed Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: cisplatin, taxotere
3 Recruiting Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Adrenal Cancer;   ACC
Intervention: Drug: ATR-101
4 Recruiting Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Peritoneal Carcinomatosis
Interventions: Drug: Cisplatin;   Procedure: Cytoreductive surgery
5 Completed A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Interventions: Drug: OSI-906;   Other: Placebo
6 Active, not recruiting Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Dovitinib
7 Completed Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Condition: Nonresectable Adrenocortical Carcinoma
Intervention: Drug: Iressa (ZD1839)
8 Recruiting German Adrenocortical Carcinoma Registry
Condition: Adrenocortical Carcinoma
Intervention:
9 Unknown  Sunitinib in Refractory Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Sunitinib
10 Terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Interventions: Drug: suramin;   Drug: therapeutic hydrocortisone
11 Active, not recruiting Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention:
12 Recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab
13 Active, not recruiting Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Cushing's Syndrome
Intervention:
14 Terminated
Has Results
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
Conditions: Recurrent Adrenocortical Carcinoma;   Stage III Adrenocortical Carcinoma;   Stage IV Adrenocortical Carcinoma
Interventions: Biological: IMC-A12;   Drug: mitotane
15 Recruiting Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Conditions: Metastatic Carcinoma in the Adrenal Cortex;   Recurrent Adrenal Cortex Carcinoma;   Stage III Adrenal Cortex Carcinoma;   Stage IV Adrenal Cortex Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nivolumab
16 Withdrawn Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Bevacizumab
17 Unknown  Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
Condition: Adrenocortical Carcinoma
Interventions: Drug: Sorafenib;   Drug: Paclitaxel
18 Completed A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Conditions: Cancer;   Neuroendocrine Tumors;   NET;   Adrenocortical Carcinoma;   ACC
Intervention: Drug: TKM-080301
19 Active, not recruiting Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Conditions: Stage I Adrenocortical Carcinoma;   Stage II Adrenocortical Carcinoma;   Stage III Adrenocortical Carcinoma;   Stage IV Adrenocortical Carcinoma
Interventions: Drug: doxorubicin hydrochloride;   Procedure: conventional surgery;   Drug: cisplatin;   Drug: mitotane;   Drug: etoposide;   Biological: filgrastim
20 Completed A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
Condition: Adrenal Cortical Carcinoma
Intervention: Drug: doxorubicin, vincristine, and etoposide with mitotane

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years